# Contact Peptides Long Island — Editorial Desk

> Reach the Peptides Long Island editorial desk regarding citations, corrections, or research-related correspondence about our Metabolic & Weight Research peptide guide.

Correspondence on citations, corrections, and research-related inquiries.

## Editorial correspondence

Peptides Long Island welcomes correspondence on the research record: a citation quoted inaccurately, a trial that has published new results, a regulatory update, or a peer-reviewed study on MOTS-c, retatrutide, or semaglutide that should be added to the [references page](/references). This class of correction is the most useful message this guide receives.

The most actionable submissions specify the page in question, the exact passage being challenged, and a supporting reference — a DOI or PubMed identifier where possible — so a proposed change can be verified before it's acted on.

**Editorial mailbox:** editors@peptideslongisland.com

## What this guide cannot do

So no message goes unanswered for the wrong reason: Peptides Long Island is a literature guide, not a clinical service, and cannot advise on human use of any peptide discussed here, suggest a dose or schedule for any individual, evaluate whether a cited finding applies to a specific person's situation, or help locate, source, or recommend a supplier for any compound. Semaglutide is a prescription medicine available only through licensed providers; retatrutide is investigational and available only within clinical trials; MOTS-c is not intended for human use. Readers seeking medical guidance should consult a licensed clinician. Responses to editorial correspondence are not guaranteed and may be delayed.

---

Peptides Long Island pairs every research finding with its citation and its caveat — a field guide to metabolic peptides, not a clinic or a store.